Christopher Schmidt, MD
Orthopaedic Surgery · Pittsburgh, PANPI 1548262579
Payments from drug & device makers
What this record shows
The money is spread across several categories — royalties or licence payments (37.8%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. Arthrex accounts for 93.1% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2021 at $22,141 and has fallen 61.4% since, to $8,556 in 2025. Among orthopaedic surgery clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 135 payments — averaging $473.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$60K
- Mid-atlantic Surgical Systems, LLC$3K
- Encore Medical, LP$620
- Catalyst Orthoscience$337
- Linvatec Corporation$92
- Zimmer Biomet$81
- plus $34 from 2 others
What the payments were for
- Royalty or licence$24,17438%
- Consulting fees$12,42019%
- Speaking & faculty fees$15,66024%
- Travel & lodging$5,8079%
- Food & beverage$2,9895%
- Education$2,9205%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 110 | $59,528 |
| Mid-atlantic Surgical Systems, LLC | 10 | $3,276 |
| Encore Medical, LP | 7 | $620 |
| Catalyst Orthoscience | 3 | $337 |
| Linvatec Corporation | 1 | $92 |
| Zimmer Biomet | 2 | $81 |
| Johnson & Johnson | 1 | $23 |
| Innovation Technologies Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$63,969 in reported general payments places this provider in the 90th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin | 33 | $49 |
| Cephalexin | 12 | $44 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Pittsburgh
- Edward WestrickPittsburgh$938K
- Timothy SauberPittsburgh$373K
- Eric YakishPittsburgh$278K
- Gary SchmidtPittsburgh$256K
- Ivan TarkinPittsburgh$243K
- Anthony DigioiaPittsburgh$217K
- Kenneth UrishPittsburgh$207K
- William HozackBensalem$10.6M
- Jess LonnerBryn Mawr$7.8M
- Gerald WilliamsBryn Mawr$6.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.